These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32622900)

  • 1. Evidence of survival benefit was often ambiguous in randomized trials of cancer treatments.
    Perneger TV; Brindel P; Combescure C; Gayet-Ageron A
    J Clin Epidemiol; 2020 Nov; 127():1-8. PubMed ID: 32622900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting and interpretation of results from clinical trials that did not claim a treatment difference: survey of four general medical journals.
    Gates S; Ealing E
    BMJ Open; 2019 Sep; 9(9):e024785. PubMed ID: 31501094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are potentially clinically meaningful benefits misinterpreted in cardiovascular randomized trials? A systematic examination of statistical significance, clinical significance, and authors' conclusions.
    Allan GM; Finley CR; McCormack J; Kumar V; Kwong S; Braschi E; Korownyk C; Kolber MR; Lindblad AJ; Babenko O; Garrison S
    BMC Med; 2017 Mar; 15(1):58. PubMed ID: 28316281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hazard ratio was estimated by a ratio of median survival times, but with considerable uncertainty.
    Cortés J; González JA; Campbell MJ; Cobo E
    J Clin Epidemiol; 2014 Oct; 67(10):1172-7. PubMed ID: 25063554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
    Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
    Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misleading reporting and interpretation of results in major infertility journals.
    Glujovsky D; Sueldo CE; Borghi C; Nicotra P; Andreucci S; Ciapponi A
    Fertil Steril; 2016 May; 105(5):1301-1306. PubMed ID: 26794424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials.
    Trinquart L; Jacot J; Conner SC; Porcher R
    J Clin Oncol; 2016 May; 34(15):1813-9. PubMed ID: 26884584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.
    Sydes MR; Altman DG; Babiker AB; Parmar MK; Spiegelhalter DJ;
    Clin Trials; 2004 Feb; 1(1):48-59. PubMed ID: 16281462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.
    Pak K; Uno H; Kim DH; Tian L; Kane RC; Takeuchi M; Fu H; Claggett B; Wei LJ
    JAMA Oncol; 2017 Dec; 3(12):1692-1696. PubMed ID: 28975263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptotic simultaneous confidence intervals for many-to-one comparisons of binary proportions in randomized clinical trials.
    Schaarschmidt F; Biesheuvel E; Hothorn LA
    J Biopharm Stat; 2009; 19(2):292-310. PubMed ID: 19212881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016.
    Ladanie A; Schmitt AM; Speich B; Naudet F; Agarwal A; Pereira TV; Sclafani F; Herbrand AK; Briel M; Martin-Liberal J; Schmid T; Ewald H; Ioannidis JPA; Bucher HC; Kasenda B; Hemkens LG
    JAMA Netw Open; 2020 Nov; 3(11):e2024406. PubMed ID: 33170262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment effects measured by restricted mean survival time in trials of immune checkpoint inhibitors for cancer.
    Liang F; Zhang S; Wang Q; Li W
    Ann Oncol; 2018 May; 29(5):1320-1324. PubMed ID: 29788167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of registered and published primary outcomes in randomized clinical trials of surgical interventions.
    Hannink G; Gooszen HG; Rovers MM
    Ann Surg; 2013 May; 257(5):818-23. PubMed ID: 23407296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dressings and topical agents for treating pressure ulcers.
    Westby MJ; Dumville JC; Soares MO; Stubbs N; Norman G
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011947. PubMed ID: 28639707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials.
    Kafadar K; Prorok PC
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):569-86. PubMed ID: 8023036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.
    Weir IR; Marshall GD; Schneider JI; Sherer JA; Lord EM; Gyawali B; Paasche-Orlow MK; Benjamin EJ; Trinquart L
    Ann Oncol; 2019 Jan; 30(1):96-102. PubMed ID: 30335127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
    Chan DLH; Segelov E; Wong RS; Smith A; Herbertson RA; Li BT; Tebbutt N; Price T; Pavlakis N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007047. PubMed ID: 28654140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
    Yang F; Markovic SN; Molina JR; Halfdanarson TR; Pagliaro LC; Chintakuntlawar AV; Li R; Wei J; Wang L; Liu B; Nowakowski GS; Wang ML; Wang Y
    JAMA Netw Open; 2020 Aug; 3(8):e2012534. PubMed ID: 32766800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.